Leerink Partners Maintains Solid Biosciences(SLDB.US) With Buy Rating, Announces Target Price $20

Moomoo NewsFeb 25 01:31 ET · Ratings

Analysts Offer Insights on Healthcare Companies: CVS Health (CVS), Solid Biosciences (SLDB) and Moderna (MRNA)

TipRanksFeb 25 00:50 ET · Ratings

Express News | Solid Biosciences Inc : Leerink Partners Cuts Target Price to $20 From $28

ReutersFeb 24 07:30 ET

William Blair Maintains Solid Biosciences(SLDB.US) With Buy Rating

Moomoo NewsFeb 24 05:32 ET · Ratings

Promising Potential of Solid Biosciences' SGT-003 Therapy Drives Buy Rating

TipRanksFeb 24 05:15 ET · Ratings

Insider Purchase: 10% Owner at $SLDB Buys 1,000,000 Shares

Quiver QuantitativeFeb 21 18:01 ET